Hans-joachim J. Anders
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 280 publications
How to treat "FSGS"? A conceptual framework.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 19, 2026
The NDT and MARKUS@HOMe Partnership.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 11, 2026
Neutrophils in Kidney Disease: Linking Neutrophil Function and Microenvironment to Therapeutic Targets.
Journal: Journal of inflammation research
Published: May 29, 2026
CCR5 and CD74 are potential therapeutic targets for necroinflammation in preclinical cholesterol crystal embolism.
Journal: Science translational medicine
Published: May 27, 2026
Author Correction: Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation.
Journal: Nature immunology
Published: March 06, 2026
Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 07, 2026
Beyond ion flux: the potassium channel KV1.3 and its regulatory function in neutrophils.
Journal: Current opinion in immunology
Published: November 26, 2025
Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.
Journal: Biochemical pharmacology
Published: November 24, 2025
Platelet Cyclophilin D Drives Cholesterol Crystal Embolism-Related Acute Kidney Injury and Kidney Infarction.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 24, 2025
Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.
Journal: Biochemical pharmacology
Published: November 24, 2025
Triple Renin-Angiotensin System/Sodium-Glucose Transporter 2/Glycogen Synthase Kinase-3 β Inhibition for the Progression of CKD in Col4a3 -/- Mice with Alport Nephropathy.
Journal: Kidney360
Published: November 07, 2025
Last Updated: 09/26/2026